About Sun Moon Pharmaceuticals Private Limited
Data last updated:
Sun Moon Pharmaceuticals Private Limited is a private limited company based in Boisar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2000PTC126022. Its GSTIN is 27AAHCS3194D1ZA (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.01 Lakh. It is led by directors Amarnath Harischandra Upadhyay and Santoshkumar Amarnath Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. N – 65 MIDC Tarapur Boisar Palghar, Maharashtra, India – 401505.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.19 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹71.33 Lakh (net margin 2.6%) and EBITDA of ₹2.48 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 19% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.18 Cr and satisfied charges of ₹88 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunmoonapi.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. N – 65 MIDC Tarapur Boisar Palghar, Maharashtra, India – 401505
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sun Moon Pharmaceuticals Private Limited
The main business activity of Sun Moon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sun Moon Pharmaceuticals Private Limited FY 2025 filings available
Sun Moon Pharmaceuticals Private Limited reported revenue of ₹27.19 Cr (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sun Moon Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 48% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sun Moon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.48 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹71.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sun Moon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sun Moon Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kay Biotech Private Limited | ₹27.33 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Riconpharma India Private Limited | ₹27.3 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Hyderabad, Telangana, India |
| Chowhan Ventures Private Limited | ₹27.27 Cr (FY 2025) | •••• | •••• | 576.0% | •••• | Bangalore, Karnataka, India |
| Kanchan Drugs Pvt Ltd | ₹27.23 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Pune, Maharashtra, India |
| Biotics Lab Life Services Private Limited | ₹27.2 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Bangalore, Karnataka, India |
| Sun Moon Pharmaceuticals Private Limited this company | ₹27.19 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Boisar, Maharashtra, India |
| Cibeles Pharmaceuticals Private Limited | ₹27.15 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Mumbai, Maharashtra, India |
| Nexgen RX Lifesciences Private Limited | ₹27.13 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Neomi Pharmaceuticals Private Limited | ₹27.12 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| HBC Healthcare Private Limited | ₹27.06 Cr (FY 2024) | •••• | •••• | 288.0% | •••• | Gandhinagar, Gujarat, India |
| Aurio Pharma Laboratories Private Limited | ₹27.02 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Sun Moon Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals Private Limited is audited by Dushyant Chaudhari & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Dushyant Chaudhari & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amarnath Harischandra Upadhyay | Director | 20 Apr 2000 | 26 Years 5 Months | Current |
| Santoshkumar Amarnath Upadhyay | Director | 19 Nov 2005 | 20 Years 10 Months | Current |
Ownership and Shareholding of Sun Moon Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sun Moon Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2023 | Others | ₹6.18 Cr | Open |
| 01 May 2022 | Others | ₹4 Cr | Open |
| 20 Sep 2021 | Others | ₹8 Lakh | Satisfied |
| 20 Sep 2021 | Others | ₹25 Lakh | Satisfied |
| 08 May 2018 | Others | ₹15 Lakh | Satisfied |
Total charge records: 6 View all charges
MSME Payment Delays by Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 6 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Parth Packaging | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals Private Limited has a workforce of 21 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals Private Limited has 2 board changes on record since 2000: 2 appointments. The latest: Santoshkumar Amarnath Upadhyay was appointed as Director on 19 Nov 2005.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sun Moon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sun Moon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCS3194D1ZA | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sun Moon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sun Moon Pharmaceuticals Private Limited
Sun Moon Pharmaceuticals is an active private limited company based in Boisar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 2000 (26+ years old) and is registered under CIN U24230MH2000PTC126022.
Sun Moon Pharmaceuticals reported revenue of ₹27.19 Cr for FY 2025 (up 48% YoY).
Sun Moon Pharmaceuticals has 2 current directors:
- Amarnath Harischandra Upadhyay - Director
- Santoshkumar Amarnath Upadhyay - Director
Sun Moon Pharmaceuticals reported a net profit of ₹71.33 Lakh (net margin 2.6%) and EBITDA of ₹2.48 Cr (EBITDA margin 9.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sun Moon Pharmaceuticals is 13% over three years and 19% over five years. In the latest year (FY 2025) revenue rose 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sun Moon Pharmaceuticals is 27AAHCS3194D1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sun Moon Pharmaceuticals is U24230MH2000PTC126022. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sun Moon Pharmaceuticals was incorporated on 20 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sun Moon Pharmaceuticals by revenue are Kay Biotech Private Limited, Riconpharma India Private Limited, Chowhan Ventures Private Limited, Kanchan Drugs Pvt Ltd, Biotics Lab Life Services Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Santoshkumar Amarnath Upadhyay was appointed as Director on 19 Nov 2005. Amarnath Harischandra Upadhyay was appointed as Director on 20 Apr 2000.
Sun Moon Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 6 overdue payments to 2 micro and small suppliers. The latest return was filed on 16 Nov 2019.
Sun Moon Pharmaceuticals can be reached through the website sunmoonapi.com. Its registered office is in Boisar, Maharashtra, India.